Lecanemab is an antibody infusion therapy, developed by pharmaceutical company Eisai, which has been shown to slow cognitive decline in the early stages of Alzheimer's disease. The drug is ...
The Albanese government has quashed any remaining questions of how it will afford a pay rise for over 60,000 aged care nurses, with the Department of Health announcing an additional $2.6 billion ...
Once these 50 new clinics open in the 2025–26 financial year, the government says four in five Australians will live within a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback